uniQure N.V - fluxo de caixa trimestral (NASDAQ:QURE) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Total de ativos 556.54 M605.4 M584.89 M888.38 M824.91 M Total de passivos 563.29 M571.72 M588.89 M659.64 M626.01 M Capital total -6.75 M33.69 M-4 M228.75 M198.9 M Total de passivos e patrimônio líquido 556.54 M605.4 M584.89 M888.38 M824.91 M Dívida total 51.32 M51.59 M51.84 M51.88 M49.7 M Dívida líquida -316.36 M-357.43 M-325.3 M-642.42 M-573.15 M

uniQure N.V

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

Notícias

Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com

Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

A Unique Situation For UniQure (QURE)

Mizuho eleva rating da uniQure após mudança na liderança do FDA

Mizuho upgrades uniQure stock rating on FDA leadership change

Avago, Lumentum among market cap stock movers on Monday

Chardan eleva preço-alvo da uniQure após mudança na liderança do FDA

Chardan raises uniQure stock price target on FDA leadership change

Tesla and Facebook among market cap stock movers on Monday

Biotech Stocks Pop After CBER Chief Exit - Moderna (NASDAQ:MRNA)